US Broker Ratings

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling the 23.34% Potential Upside and Strategic Collaborations

Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, is making waves with its innovative approach to health information services. Headquartered in Chicago, Illinois, this company has..

Amgen Inc. (AMGN) Stock Analysis: High ROE and Promising Dividend Yield Position Healthcare Giant for Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, stands out with its impressive market capitalization of $159.59 billion. As a leader in the drug manufacturing industry, Amgen’s portfolio..

Moderna, Inc. (MRNA) Stock Analysis: Exploring 63% Potential Upside Amidst Current Market Challenges

In the ever-evolving landscape of biotechnology, Moderna, Inc. (NASDAQ: MRNA) stands out as a leading innovator with a diverse portfolio of mRNA-based medicines. Despite recent market challenges, the company presents..

Boston Scientific Corporation (BSX) Stock Analysis: A Compelling 17.77% Upside Awaits Investors

Boston Scientific Corporation (NYSE: BSX) stands out in the healthcare sector with a market capitalization of $156.19 billion, making it a heavyweight in the medical devices industry. The company’s extensive..

Hologic, Inc. (HOLX) Stock Analysis: Unveiling a 7.21% Potential Upside in the Healthcare Sector

Hologic, Inc. (HOLX), a prominent player in the healthcare sector, specializes in developing and supplying a wide range of diagnostic products and medical imaging systems, particularly those aimed at improving..

Teva Pharmaceutical Industries (TEVA): Investor Outlook with a 52% Potential Upside

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a key player in the global healthcare sector, offers a compelling opportunity for investors seeking exposure to the drug manufacturing industry. Headquartered in Tel..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 32.40% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a key player in the diagnostics and research industry, has captured the attention of investors with its significant potential upside of 32.40%, as per recent analyst ratings...

Sanofi (SNY) Investor Outlook: Exploring a 32.98% Potential Upside

Sanofi (SNY), a global healthcare titan based in Paris, stands at a pivotal juncture for individual investors seeking robust opportunities within the pharmaceutical sector. With a market capitalization of $114.02..

Encompass Health Corporation (EHC) Stock Analysis: Navigating a 21% Upside with Robust Growth Potential

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, specifically in the medical care facilities industry, has been catching the eye of investors with its resilient growth..

Cencora, Inc. (COR) Stock Analysis: Unveiling 14% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a leading entity in the healthcare sector, has been making waves in the medical distribution industry with its robust operational strategies and global reach. Formerly known..

United Therapeutics Corporation (UTHR): Investor Outlook on a Potential 28% Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $13.31 billion, this biotechnology company..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a 15% Upside Potential in Medical Distribution

Cardinal Health, Inc. (NYSE: CAH) stands as a titan in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $37.23 billion, this Ohio-based company extends..

Incyte Corporation (INCY) Stock Analysis: Exploring Growth Potential with a 5.66% Upside

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of $14.76 billion,..

Agilent Technologies (A) Stock Analysis: Exploring a 20.66% Potential Upside and Strong Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, stands out in the diagnostics and research industry with a market capitalization of $32.24 billion. Headquartered in Santa..

Abbott Laboratories (ABT) Stock Analysis: Exploring a Promising 11.94% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to captivate investor interest with its robust market presence and innovative product offerings. Headquartered in North Chicago, Illinois, Abbott..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Giant with a 16.77% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector with a strong focus on diagnostics and research, presents an intriguing opportunity for investors looking to capitalize on its..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking Growth in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $43.07 billion,..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Leader’s 25.86% ROE Signals Robust Growth Potential

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, stands out in the medical instruments and supplies industry with an impressive market capitalization of $40.94 billion. Headquartered in San..

Novo Nordisk A/S (NVO) Investor Outlook: Massive 52.57% Potential Upside Amid Robust Revenue Growth

Investors eyeing the pharmaceutical sector should take a closer look at Novo Nordisk A/S (NYSE: NVO), a Denmark-based titan in the healthcare industry, with a market capitalization of $209.97 billion...

Edwards Lifesciences Corporation (EW) Stock Analysis: A 9.56% Potential Upside Amidst Strong Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, specifically within the medical devices industry, has long been at the forefront of innovations in cardiovascular treatments. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds